A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)

9 Feb 2025 9:36 a.m. 9:54 a.m.
JonathanBarratt Oral Abstract Presenter United KingdomUniversity of Leicester, Leicester, UK